Ackerly D Clay, Valverde Ana M, Diener Lawrence W, Dossary Kristin L, Schulman Kevin A
Center forClinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Health Aff (Millwood). 2009 Jan-Feb;28(1):w68-75. doi: 10.1377/hlthaff.28.1.w68. Epub 2008 Dec 2.
Innovation in health care requires new ideas and the capital to develop and commercialize those ideas into products or services. The necessary capital is often "venture capital," but the link between public policy and the venture capital industry has not been well examined. In this paper we explore the link between venture capital and innovation in health care, and we present new descriptive data from a survey of health care venture capital fund managers. Respondents generally viewed policy levers (for example, reimbursement and regulations) as important risks to venture capital investments, potentially affecting their ability to raise capital for early-stage investment funds.
医疗保健领域的创新需要新想法以及将这些想法开发并商业化成产品或服务的资金。所需资金通常是“风险资本”,但公共政策与风险资本行业之间的联系尚未得到充分研究。在本文中,我们探讨了风险资本与医疗保健创新之间的联系,并展示了一项针对医疗保健风险资本基金经理的调查得出的新描述性数据。受访者普遍认为政策杠杆(例如报销和监管)是风险资本投资的重要风险,可能会影响他们为早期投资基金筹集资金的能力。